Jump to content


Do you want up to date information about Scleroderma? Check out our Medical pages at www.sclero.org for all your Scleroderma questions!


Photo

N-acetylcysteine (NAC) attenuates subcutaneous administration of bleomycin (BLM)-induced skin fibrosis and oxidative stress in a mouse model of scleroderma.

digital ulcers

  • Please log in to reply
No replies to this topic

#1 Joelf

Joelf

    Star Ruby Member

  • ISN Root Admin
  • PipPipPipPipPipPipPipPipPipPipPipPipPip
  • 4,505 posts
  • Location:West Sussex

Posted 24 June 2013 - 10:51 AM

N-acetylcysteine (NAC) attenuates subcutaneous administration of bleomycin (BLM)-induced skin fibrosis and oxidative stress in a mouse model of scleroderma.

 

The results suggest that NAC may be a potential therapeutic agent for patients with scleroderma. Clinical and Experimental Dermatology, 2013 Mar 21. (Also see: Digital Ulcer Treatments)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.


Jo Frowde
ISN Assistant Webmaster
ISN Sclero Forums Manager
ISN News Manager

ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)